These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397 [TBL] [Abstract][Full Text] [Related]
4. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY). Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G; JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420 [TBL] [Abstract][Full Text] [Related]
5. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ; Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ; JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Doyle B; Rihal CS; O'Sullivan CJ; Lennon RJ; Wiste HJ; Bell M; Bresnahan J; Holmes DR Circulation; 2007 Nov; 116(21):2391-8. PubMed ID: 17984377 [TBL] [Abstract][Full Text] [Related]
8. Late occlusive in-stent restenosis of a bare-metal stent presenting with ST-elevation anterior MI: is restenosis better than a late stent thrombosis? Trabattoni D; Bartorelli AL Int J Cardiol; 2009 Jun; 135(2):e65-7. PubMed ID: 18644635 [TBL] [Abstract][Full Text] [Related]
9. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era. Rodriguez AE Expert Opin Emerg Drugs; 2009 Dec; 14(4):561-76. PubMed ID: 19712016 [TBL] [Abstract][Full Text] [Related]
11. Cocaine-induced very late stent thrombosis. Shah P; Vasudev R; Abuarqoub AH; Shamoon F BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27733418 [TBL] [Abstract][Full Text] [Related]